Good evening :)
$
₹
Quest Diagnostics Incorporated

Quest Diagnostics Incorporated

DGX

NYSE
Asset Logo

Quest Diagnostics Incorporated

DGX

NYSE
$246.430.41% (-1.01)
$
₹
$246.430.41% (-1.01)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
Loading...
1D
1W
1M
1Y
5Y
Max

Healthcare

Diagnostics & Research

Large Cap

With a market cap of $27.3B the stock is ranked 504

Key Metrics

Key Metrics

PE TTM
PE TTM

Close price divided by the earnings per share for the trailing twelve months

26.25
PB
PB

Close price divided by the book value per share at the end of the most recent quarter

3.62
EPS TTM
EPS TTM

Net profit earned per share over the trailing twelve months (sum of the last 4 quarters)

$9.41
PEG Ratio
PEG Ratio

Price-to-Earnings (P/E) ratio divided by the forecasted annual earnings per share (EPS) growth rate over the next five years

1.91
Profit Margin
Profit Margin

Net profit divided by the total revenue for the most recent financial year

9.19%
Dividend Yield
Dividend Yield

Annual dividend per share for the trailing twelve months divided by the close price

1.34%

Analyst Ratings & Forecast
Analyst Ratings & Forecast

Based on 18 analysts' reports

Buy
9 analysts
Hold
9 analysts
Sell
0 analyst

Analysts expect a -0.29% price downside over the next year

Current Price$246.43
Target Price$246.73

Company Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; healthcare IT healthcare providers and payers; testing and medical director services at hospital laboratories; test offerings in cardiometabolic and endocrine; cancer; clinical drug monitoring and toxicology; infectious disease, including autoimmune; neurology diagnostics, including Alzheimer's disease; and women's health, such as prenatal genetic; workplace drug testing, testing urine, hair, and oral fluid specimens services; and employer population health services, including biometric screenings, flu shots, and related preventative services. Further, it provides population health solutions; extended care services; develops in vitro diagnostic tests; laboratory diagnostic information and digital health connectivity systems; underwriting support services, including data gathering, paramedical examinations, and clinical laboratory testing and analytics; and national specimen collection and health data solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Peers

Peers

CVS Health Corp
CVS
CVS Health Corp
P/E Ratio
24.92
24.92
1Y Return
22.28%
22.28%
Buy Reco %
85.71
85.71
Cigna Corp
CI
Cigna Corp
P/E Ratio
11.94
11.94
1Y Return
6.04%
6.04%
Buy Reco %
76.00
76.00
Laboratory Corporation of America Holdings
LH
Laboratory Corporation of America Holdings
P/E Ratio
26.81
26.81
1Y Return
16.02%
16.02%
Buy Reco %
80.00
80.00
Guardant Health Inc
GH
Guardant Health Inc
P/E Ratio
—
—
1Y Return
211.39%
211.39%
Buy Reco %
95.65
95.65
DaVita HealthCare Partners Inc
DVA
DaVita HealthCare Partners Inc
P/E Ratio
16.18
16.18
1Y Return
40.58%
40.58%
Buy Reco %
10.00
10.00

Peers & Comparison

Peers & Comparison

Comparing 2 stocks from
HealthcareDiagnostics & Research

Valuation

Returns

Forecast

StockPE TTMPE TTMPBPBPEG RatioPEG Ratio
Quest Diagnostics Incorporated 26.253.621.91
CVS Health Corp24.921.510.22
Cigna Corp11.941.790.78

Price Comparison

Price Comparison

1 Month

1 Year

5 Years

Loading...

Financials

Financials

Income

Balance Sheet

Cash Flow

2.8
0.2
2.8
0.2
2.8
0.2
3
0.3
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Revenue
Net Income
Financial YearQ1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Total Revenue2.362.392.482.622.652.762.812.802.893.04
Net Income0.190.220.220.220.220.280.240.240.250.32
Net Profit Margin8.19%9.55%9.08%8.47%8.29%10.21%8.70%8.73%8.70%10.51%
See CostsAll values in $ Billion

Frequently asked questions

Frequently asked questions

  1. Quest Diagnostics Incorporated (DGX) share price today is $246.43 as of September 19, 2026 at 1:30 AM IST. The stock touched a day high of $247.15 and a day low of $244.45.

  2. Quest Diagnostics Incorporated stock trades on NYSE under the ticker symbol DGX.

  3. Quest Diagnostics Incorporated's market capitalization is $27.27B as of September 19, 2026 at 1:30 AM IST.

  4. Quest Diagnostics Incorporated's price-to-earnings (P/E) ratio is 26.25 as of September 18, 2026.

  5. Quest Diagnostics Incorporated's price-to-book (P/B) ratio is 3.62 as of September 18, 2026.

  6. Yes, Quest Diagnostics Incorporated pays a dividend, with a current dividend yield of 1.34%.

  7. Yes, You can buy Quest Diagnostics Incorporated shares from India through Tickertape, via our partnership with ViewTrade IFSC under the IFSCA Global Access framework, subject to RBI’s Liberalised Remittance Scheme (LRS) limits.

  8. Indian investors can buy Quest Diagnostics Incorporated shares in three steps: 1. Search Quest Diagnostics Incorporated on the Tickertape app and tap Invest. 2. Complete your one-time digital KYC. 3. Fund your account and buy from as low as $1 via fractional shares.

  9. Since Quest Diagnostics Incorporated trades in USD, an Indian investor's INR returns depend on both the stock's price movement and the USD-INR exchange rate. If the rupee depreciates against the dollar, INR returns are boosted beyond the stock's USD return; if the rupee appreciates, INR returns are reduced.

  10. Indian investors can start investing in Quest Diagnostics Incorporated (DGX) shares from as little as $1 through fractional ownership on Tickertape - for example, $10 buys approximately 0.0405 shares at the current price of $246.43.

Loading...